Mosley Wealth Management acquired a new position in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 778 shares of the company’s stock, valued at approximately $367,000.
Other hedge funds have also modified their holdings of the company. Richwood Investment Advisors LLC grew its position in Elevance Health by 0.8% in the fourth quarter. Richwood Investment Advisors LLC now owns 2,546 shares of the company’s stock valued at $1,201,000 after purchasing an additional 20 shares in the last quarter. Alliance Wealth Advisors LLC raised its stake in Elevance Health by 2.9% in the fourth quarter. Alliance Wealth Advisors LLC now owns 745 shares of the company’s stock valued at $351,000 after buying an additional 21 shares during the period. Clearstead Advisors LLC boosted its stake in shares of Elevance Health by 0.9% during the 3rd quarter. Clearstead Advisors LLC now owns 2,516 shares of the company’s stock worth $1,096,000 after acquiring an additional 22 shares during the period. Sugarloaf Wealth Management LLC increased its holdings in shares of Elevance Health by 8.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 277 shares of the company’s stock worth $131,000 after acquiring an additional 22 shares during the last quarter. Finally, Capital Investment Advisors LLC raised its stake in Elevance Health by 2.5% in the 4th quarter. Capital Investment Advisors LLC now owns 887 shares of the company’s stock valued at $418,000 after acquiring an additional 22 shares during the period. 89.24% of the stock is currently owned by institutional investors.
Contents
Insider Activity
In other Elevance Health news, EVP Felicia F. Norwood sold 14,111 shares of Elevance Health stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $533.74, for a total transaction of $7,531,605.14. Following the transaction, the executive vice president now directly owns 31,460 shares of the company’s stock, valued at approximately $16,791,460.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.29% of the stock is currently owned by insiders.
Elevance Health Price Performance
Shares of ELV stock opened at $538.94 on Monday. The business has a fifty day simple moving average of $526.51 and a 200 day simple moving average of $503.08. The company has a market cap of $125.26 billion, a P/E ratio of 20.37, a P/E/G ratio of 1.19 and a beta of 0.83. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 0.54. Elevance Health, Inc. has a twelve month low of $412.00 and a twelve month high of $550.34.
Elevance Health (NYSE:ELV – Get Free Report) last announced its quarterly earnings results on Thursday, April 18th. The company reported $10.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.54 by $0.10. The company had revenue of $42.27 billion for the quarter, compared to analyst estimates of $42.49 billion. Elevance Health had a net margin of 3.64% and a return on equity of 20.62%. The firm’s revenue was up .9% on a year-over-year basis. During the same period in the previous year, the firm posted $9.46 EPS. On average, sell-side analysts forecast that Elevance Health, Inc. will post 37.26 EPS for the current fiscal year.
Elevance Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 10th will be issued a dividend of $1.63 per share. This represents a $6.52 annualized dividend and a dividend yield of 1.21%. The ex-dividend date is Monday, June 10th. Elevance Health’s dividend payout ratio (DPR) is currently 24.64%.
Analysts Set New Price Targets
ELV has been the topic of several research analyst reports. Mizuho increased their price objective on shares of Elevance Health from $575.00 to $585.00 and gave the company a “buy” rating in a research report on Wednesday, April 24th. Robert W. Baird started coverage on shares of Elevance Health in a research report on Thursday, May 30th. They set an “outperform” rating and a $649.00 price objective for the company. Royal Bank of Canada boosted their price objective on Elevance Health from $574.00 to $575.00 and gave the stock an “outperform” rating in a report on Friday, April 19th. Truist Financial reiterated a “buy” rating and set a $600.00 target price (up previously from $580.00) on shares of Elevance Health in a research note on Friday, April 19th. Finally, Jefferies Financial Group boosted their price target on Elevance Health from $602.00 to $604.00 and gave the company a “buy” rating in a research note on Friday, April 19th. One investment analyst has rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Elevance Health presently has a consensus rating of “Buy” and a consensus price target of $601.64.
Read Our Latest Report on ELV
Elevance Health Profile
(Free Report)
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Recommended Stories
- Five stocks we like better than Elevance Health
- Do ETFs Pay Dividends? What You Need to Know
- Invesco QQQ and Nasdaq-100 Analysis: Key Market Trends
- What Is WallStreetBets and What Stocks Are They Targeting?
- HealthEquity Stock: Leading Health Savings Account Investment
- Investing in Construction Stocks
- Why Taiwan Semiconductor’s Stock Prices Hit Record Highs